Replies to post #251581 on Elite Pharmaceuticals Inc (ELTP)

[NASDAQ2020]

11 Roads to DollarLand

1.) First ever Immediate Release ADF labeled opiod with ORAL AD Labeling
using the Pharmacological Approach
----------- Reformulated SequestOx™ ----------
2.) First ever generic ER ADF labeled Oxycodone ELI-201
3.) First ever generic Embeda®
4.) First ever generic Troxyca®
5.) A couple $50-100 million dollar ANDAs
6.) First ever Abuse Deterrent generic of reformulated OxyContin®
7.) File Huge Blockbuster Undisclosed NDA
8.) Lauch All four SunGen generics
9.) Buyout/Acquisition
10.)Mega Partnership !!!!
11.)Uplisting to NASDAQ exchange

$ELTP

[Couch]

Lets stick with FACTS

Indeed and here are the FACTS:

The FDA has GREEN LIGHTED the SequestOx path to approval $$$$$$$$$$$

RESULTS coming by MID MAY!!!!

Elite Pharmaceuticals, Inc. Initiates Pivotal Bioequivalence Fed Study For Reformulated SequestOx™

NORTHVALE, N.J., March 13, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP), announced today that it has initiated pharmacokinetic testing of its reformulated SequestOx™. The reformulated product is expected to have a shorter Tmax under fed conditions. Elite is conducting a bioequivalence study which is a pivotal, open-label, randomized, single-dose, three-way, crossover study to evaluate the relative comparative bioavailability and bioequivalence of the modified formulation of SequestOx™ to the original formulation of SequestOx™ and to a comparator product under fed conditions. The study has enrolled forty-five healthy volunteers and the first subjects have been dosed.

SequestOx™ is Elite's investigational immediate-release oxycodone with sequestered naltrexone abuse-deterrent opioid product for the management of moderate to severe acute pain where the use of an opioid analgesic is appropriate.

"We are pleased to have this bioequivalence study underway for SequestOx™," commented Nasrat Hakim, President and CEO of Elite. "We are expecting results for this study by the middle of May and re-submitting the NDA prior to the end of the year."

[jour_trader]

Please let me know the last time Elite has did not hold a quarterly call. There is no reason to believe they will diverge from past practices. Companies don't announce a whole year of CC's all at once. We'll hear a specific date 1-2 weeks before the call when an 8-k is filed.